middle.news
Saluda Medical Raises FY26 Revenue Forecast After Strong Q2 Surge
8:36am on Wednesday 28th of January, 2026 AEDT
•
Healthcare
Read Story
Saluda Medical Raises FY26 Revenue Forecast After Strong Q2 Surge
8:36am on Wednesday 28th of January, 2026 AEDT
Key Points
Q2 FY26 global revenue up 19.9% year-on-year to US$21 million
US implanted patients and active physicians increased by over 20%
FY26 revenue guidance raised to US$85 million, a 21% increase over FY25
Regulatory approval secured for EVA™ Sensing Technology in Europe and Australia
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
SALUDA MEDICAL, (ASX:SLD)
OPEN ARTICLE